Sign Up to like & get
recommendations!
1
Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2437_51
Abstract: Non‐Hodgkin's lymphoma‐tailored small compound inhibitors of BCR signaling, ibrutinib and idelalisib, where dramatic death rates were observed after priming with two restore agents. Further investigations, including pre‐clinical mouse trials, are currently in progress and will…
read more here.
Keywords:
lymphoma liquid;
classical hodgkin;
hodgkin lymphoma;
genotyping classical ... See more keywords